Share：
Share this content in WeChat
X
[Chinese][PDF]130483
• Paying a Tribute to 70 Years of Healthcare Development •
CMR in China of the last 30 years
LU Minjie  ZHAO Shihua 

Cite this article as: Lu MJ, Zhao SH. CMR in China of the last 30 years. Chin J Magn Reson Imaging, 2019, 10(10): 727-731. DOI:10.12015/issn.1674-8034.2019.10.002.


[Abstract] Cardiac magnetic resonance (CMR) is a non-invasive imaging technology, gradually playing an irreplaceable role in the diagnosis and treatment of cardiovascular diseases. This review demonstrates the progress and research highlights of Chinese CMR research in the past 30 years. From the end of the 1980s to the end of the 1990s, the domestic researchers, under the guidance of Prof. Liu Yuqing and other seniors, carried out arduous explorations based on foreign equipment. They focused on the evaluation of cardiac anatomy and ventricular function in CMR. At the turn of the century, China's CMR had reached to the development period (2000-2010). Some young talents had received professional training abroad and made a fine figure after returning to China. Through their efforts, China's cardiovascular industry had a quick leap. In the meantime, with the perfection and improvement of magnetic resonance imaging equipment and technology, especially the histological characterization represented by gadolinium contrast enhancement, it was realized that CMR was not only the gold standard for assessing the structure and function of cardiovascular diseases, but it played an important role in the prognosis evaluation of the diseases. Since 2010, China's CMR has entered a period of comprehensive prosperity, and begun to be in line with international standards. It has truly achieved the "one-stop" examination in CMR, which completed a comprehensive measurement of the morphology, function, histology, perfusion, blood flow, qualitative and quantitative analysis of microstructures and the like. Along with the rise of domestically produced equipment, unique in some respects, it is now urgent to promote and popularize CMR in China.
[Keywords] cardiovascular magnetic resonance；cardiomyopathy；coronary heart disease

LU Minjie Peking Union Medical College, Chinese Academy of Medical Sciences, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, Beijing 100037, China

ZHAO Shihua * Peking Union Medical College, Chinese Academy of Medical Sciences, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, Beijing 100037, China

*Corresponding to: Zhao SH, E-mail: cjr.zhaoshihua@vip.163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Natural Science Foundation of China No. 81771811, 81571647, 81620108015
Received  2019-07-24
DOI: 10.12015/issn.1674-8034.2019.10.002
Cite this article as: Lu MJ, Zhao SH. CMR in China of the last 30 years. Chin J Magn Reson Imaging, 2019, 10(10): 727-731. DOI:10.12015/issn.1674-8034.2019.10.002.

[1]
夏宗织. 1986年磁共振对心脏临床诊断的概论．心血管病学进展, 1988, 1(1): 45-47.
[2]
曾仁端．心电图门控的心脏磁共振成像．中国医学影像技术, 1989, 1(1): 6-7.
[3]
齐建华，姚庆华．影象诊断学——心脏功能的磁共振成象评价．国外医学临床放射学分册, 1990, 1(6): 321-324.
[4]
李坤成，刘玉清，王新民．心肌梗死室壁瘤的MRI诊断．中华放射学杂志, 1997, 31(5): 20-23.
[5]
陈翰高，龙莉玲，李茂，等．电影磁共振正常心脏测量及心内膜心肌纤维化症研究．广西医科大学学报, 1999, 1(6): 32-34.
[6]
Wang R, Zhang ZQ, Xu L, et al. Low dose prospective ECG-gated delayed enhanced dual-source computed tomography in reperfused acute myocardial infarction comparison with cardiac magnetic resonance. Eur J Radiol, 2011, 80(2): 326-330.
[7]
He Y, Zhang ZQ, Hong DJ, et al. Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy. J Cardiovasc Magn Reson, 2010, 12(1): 1-3.
[8]
Ma XG, Zhang ZQ, Fan ZM, et al. Natural history of spontaneous aortic intramural hematoma progression: Six years follow-up with cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2010, 12(1): 27.
[9]
Liang B, Kong X, Han P, et al. A comparative study of MR imaging, echocardiography and X-ray angiography in complex congenital heart disease. J Clin Radiol, 2000, 1(6): 346-350.
[10]
Guo YK, Yang ZG, Ning G. Isolated mitral regurgitation: quantitative assessment with 64-section multidetector CT--comparison with MR imaging and echocardiography. Radiology, 2009, 252(2): 369-376.
[11]
Ju SH, Teng GJ, Lu HH, et al. In vivo MR tracking of magnetically labeled mesenchymal stem cells in rat liver after intrasplenic transplantation. Radiology, 2007, 245(1): 206-215.
[12]
Ju SH, Teng GJ, Lu HH, et al. In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver. Invest Radiol, 2010, 45(10): 625.
[13]
Ju SH, Teng GJ, Zhang Y, et al. In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood. Magn Reson Imaging, 2006, 24(5): 611-617.
[14]
Lu MJ, Zhao SH, Wei YQ, et al. Detection of viable myocardium by low dose of dobutamine cine MR imaging in miniswine. Chin J Cardiol, 2003, 116(6): 893-896.
[15]
Liu Q, Zhao SH, Yan ZW, et al. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography. Nual Med Commun, 2009, 30(8): 610.
[16]
陆敏杰，赵世华，蒋世良，等．磁共振成像在致心律不齐性右室型心肌病的诊断价值．中华心血管病杂志, 2006, 34(12): 1077-1080.
[17]
万俊义，赵世华．心脏磁共振钆对比剂延迟强化的临床意义及判断预后的价值．中国医学影像技术, 2012, 28(8): 1600-1603.
[18]
Yan CW, Zhao SH, Ling J, et al. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy. Circ Heart Fail, 2013, 6(5): 1013-1020.
[19]
Fan H, Li S, Lu M, et al. Myocardial late gadolinium enhancement: a head-to-head comparison of motion-corrected balanced steady-state free precession with segmented turbo fast low angle shot. Clin Radiol, 2018, 73(6): 591-593, 599.
[20]
Li W, Yang T, Zhang Y, et al. Characteristics of pulmonary arterial flow derived from phase contrast magnetic resonance imaging in patients with pulmonary arterial hypertension: correlations with right ventricular function and hemodynamics. Int J Clin Exp Med, 2016, 9(12): 23386-23396.
[21]
Sun AQ, Zhao B, Li YD, et al. Real-time phase-contrast flow cardiovascular magnetic resonance with low-rank modeling and parallel imaging. J Cardiovasc Magn Reson, 2017, 19(6): 13.
[22]
刘红，杨丹，罗勇，等．特征追踪心脏磁共振技术测量汉族健康人群左心室心肌应变正常参考值的研究．四川大学学报（医学版）, 2016, 47(4): 599-604.
[23]
杨映霞，汪芳，尹刚，等．基于心脏磁共振特征追踪技术的中国正常人左心房功能的定量研究．第二军医大学学报, 2019, 40(3): 250-256.
[24]
Wang J, Li W, Sun J, et al. Improved segmental myocardial strain reproducibility using deformable registration algorithms compared with feature tracking cardiac MRI and speckle tracking echocardiography. J Magn Reson Imaging, 2018, 48(2): 404-414.
[25]
Lu M, Zhao S, Yin G, et al. T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: a preliminary study. Eur J Radiol, 2013, 82(5): e225-231.
[26]
Shang Y, Zhang X, Leng W, et al. Assessment of diabetic cardiomyopathy by cardiovascular magnetic resonance T1 mapping: Correlation with left-ventricular diastolic dysfunction and diabetic duration. J Diabetes Res, 2017, 2017: 9584278.
[27]
Wang S, Hu H, Lu M, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Eur Radiol, 2017, 27(11): 4620-4630.
[28]
Liu X, Hou JL, Yang ZG, et al. Native T1 mapping for characterization of acute and chronic myocardial infarction in swine: Comparison with contrast-enhanced MRI. J Magn Reson Imaging, 2018, 47(5): 1406.
[29]
Yang Q, Li KC, Liu X, et al. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T a comparative study with X-ray angiography in a single center. J Am Coll Cardiol, 2009, 54(1): 69-76.
[30]
Lu M, Zhao S, Jiang S, et al. Fat deposition in dilated cardiomyopathy assessed by CMR. JACC, 2013, 6(8): 889-898.
[31]
Wu B, Lu M, Zhang Y, et al. CMR assessment of the left ventricle apical morphology in subjects with unexplainable giant T-wave inversion and without apical wall thickness >= 15mm. Eur Heart J Cardiovasc Imaging, 2017, 18(2): 186-194.
[32]
Lu M, Du H, Gao Z, et al. Predictors of outcome after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: An echocardiography and cardiovascular magnetic resonance imaging study. Circ Cardiovasc Interv, 2016, 9(3): 2675.
[33]
He Y, Pang J, Dai Q, et al. Diagnostic performance of self-navigated whole-heart contrast-enhanced coronary 3.0 T MR angiography. Radiology, 2016, 281(2): 401-408.
[34]
Lin L, Li X, Feng J, et al. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis. J Cardiovasc Magn Reson, 2018, 20(1): 22-25.
[35]
Liu W, Xie Y, Wang C, et al. Atherosclerosis T1-weighted characterization (CATCH): evaluation of the accuracy for identifying intraplaque hemorrhage with histological validation in carotid and coronary artery specimens. J Cardiovasc Magn Reson, 2018, 20(1): 27.
[36]
赵世华．心血管病磁共振诊断学．北京：人民军医出版社, 2011: 1-256.
[37]
中华医学会心血管病学分会, 中国医师协会心血管内科医师分会, 中华心血管病杂志编辑委员会．心肌病磁共振成像临床应用中国专家共识．中华心血管病杂志, 2015, 43(8): 673-681.

PREV The review and the future of functional magnetic resonance imaging
NEXT Analysis of MRI configuration and operation status of county hospitals in Yunnan province
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn